JP2019073535A5 - - Google Patents

Download PDF

Info

Publication number
JP2019073535A5
JP2019073535A5 JP2019003596A JP2019003596A JP2019073535A5 JP 2019073535 A5 JP2019073535 A5 JP 2019073535A5 JP 2019003596 A JP2019003596 A JP 2019003596A JP 2019003596 A JP2019003596 A JP 2019003596A JP 2019073535 A5 JP2019073535 A5 JP 2019073535A5
Authority
JP
Japan
Prior art keywords
injection
oral preparation
extract
measured
per
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2019003596A
Other languages
English (en)
Japanese (ja)
Other versions
JP6943894B2 (ja
JP2019073535A (ja
Filing date
Publication date
Priority claimed from JP2015514860A external-priority patent/JP6469002B2/ja
Application filed filed Critical
Publication of JP2019073535A publication Critical patent/JP2019073535A/ja
Publication of JP2019073535A5 publication Critical patent/JP2019073535A5/ja
Application granted granted Critical
Publication of JP6943894B2 publication Critical patent/JP6943894B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2019003596A 2013-04-30 2019-01-11 抽出物及び該抽出物を含有する製剤 Active JP6943894B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2013095565 2013-04-30
JP2013095565 2013-04-30
JP2015514860A JP6469002B2 (ja) 2013-04-30 2014-04-30 抽出物及び該抽出物を含有する製剤

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2015514860A Division JP6469002B2 (ja) 2013-04-30 2014-04-30 抽出物及び該抽出物を含有する製剤

Publications (3)

Publication Number Publication Date
JP2019073535A JP2019073535A (ja) 2019-05-16
JP2019073535A5 true JP2019073535A5 (https=) 2019-11-14
JP6943894B2 JP6943894B2 (ja) 2021-10-06

Family

ID=51843519

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2015514860A Active JP6469002B2 (ja) 2013-04-30 2014-04-30 抽出物及び該抽出物を含有する製剤
JP2018097403A Active JP6680829B2 (ja) 2013-04-30 2018-05-21 抽出物及び該抽出物を含有する製剤
JP2019003596A Active JP6943894B2 (ja) 2013-04-30 2019-01-11 抽出物及び該抽出物を含有する製剤

Family Applications Before (2)

Application Number Title Priority Date Filing Date
JP2015514860A Active JP6469002B2 (ja) 2013-04-30 2014-04-30 抽出物及び該抽出物を含有する製剤
JP2018097403A Active JP6680829B2 (ja) 2013-04-30 2018-05-21 抽出物及び該抽出物を含有する製剤

Country Status (9)

Country Link
US (1) US9884077B2 (https=)
EP (1) EP2992889B1 (https=)
JP (3) JP6469002B2 (https=)
KR (1) KR102182240B1 (https=)
CN (3) CN115629169A (https=)
AU (1) AU2014260736B2 (https=)
CA (1) CA2909234C (https=)
TW (2) TWI737229B (https=)
WO (1) WO2014178394A1 (https=)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103357006B (zh) 2012-10-10 2014-10-15 日本脏器制药株式会社 含有提取物的制剂的检查方法
WO2014178394A1 (ja) * 2013-04-30 2014-11-06 日本臓器製薬株式会社 抽出物及び該抽出物を含有する製剤
TWI711456B (zh) * 2015-05-29 2020-12-01 日商日本臟器製藥股份有限公司 牛痘病毒接種炎症組織萃取物及其用途以及其判定或評估方法
AU2018394182B2 (en) * 2017-12-28 2024-08-08 Hyogo College Of Medicine Lipocalin-type prostaglandin D2 synthase production accelerating agent
CN113267574A (zh) * 2020-02-17 2021-08-17 上海交通大学医学院附属瑞金医院 O-硫化酪氨酸的检测方法及其用途

Family Cites Families (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB697351A (en) 1951-01-16 1953-09-23 Masuichi Takino Improved process for the manufacture of nerve sedatives
JPS53101515A (en) 1977-02-17 1978-09-05 Nippon Zoki Pharmaceutical Co Medicine having anodyne * sedative and antiallergic activity and production thereof
JPS5587724A (en) 1978-12-27 1980-07-02 Nippon Zoki Pharmaceut Co Ltd Selective immune enhancer
JPS5777697A (en) 1980-11-04 1982-05-15 Nippon Zoki Pharmaceut Co Ltd Physiologically active substance nsq
JPS5835117A (ja) 1981-08-25 1983-03-01 Nippon Zoki Pharmaceut Co Ltd 新規生理活性物質nsh
JP2651674B2 (ja) 1987-07-23 1997-09-10 日本臓器製薬 株式会社 新規生理活性物質及びその製造方法
JPS6479657A (en) 1987-09-22 1989-03-24 Nippon Zoki Pharmaceutical Co Vital decision of medicine
US4985254A (en) 1987-11-06 1991-01-15 Nippon Zoki Pharmaceutical Co., Ltd. Method of treating ischemic diseases
JPH0825885B2 (ja) 1988-04-15 1996-03-13 日本臓器製薬株式会社 特発性血小板減少性紫斑病治療剤
ATE94401T1 (de) 1988-04-30 1993-10-15 Nippon Zoki Pharmaceutical Co Physiologisch wirkende substanzen, verfahren zu ihrer herstellung und pharmazeutische zusammensetzungen davon.
JP2539665B2 (ja) 1988-06-20 1996-10-02 日本臓器製薬株式会社 神経疾患治療剤
JP2539669B2 (ja) 1988-07-15 1996-10-02 日本臓器製薬株式会社 糖尿病性神経障害治療剤
JPH06273415A (ja) * 1993-03-18 1994-09-30 Unitika Ltd コレシストキニンの測定用試薬及び測定方法
JP2594222B2 (ja) 1993-09-28 1997-03-26 日本臓器製薬株式会社 新規生理活性物質−kf
JP3852786B2 (ja) 1995-04-25 2006-12-06 日本臓器製薬株式会社 骨萎縮改善剤
JP4033936B2 (ja) 1997-01-08 2008-01-16 日本臓器製薬株式会社 一酸化窒素産生抑制剤
JPH1180005A (ja) 1997-09-12 1999-03-23 Nippon Zoki Pharmaceut Co Ltd 骨粗鬆症治療剤
JPH11139977A (ja) * 1997-11-07 1999-05-25 Nippon Zoki Pharmaceut Co Ltd Nef作用抑制剤
KR19990044835A (ko) 1997-11-28 1999-06-25 고니시 진우에몬 생약추출물
EP0953352A1 (en) 1998-04-27 1999-11-03 Nippon Zoki Pharmaceutical Co., Ltd. A therapeutic agent for ischemic diseases
JP2000016942A (ja) 1998-04-27 2000-01-18 Nippon Zoki Pharmaceut Co Ltd 虚血性疾患治療剤
US6306345B1 (en) 1998-05-06 2001-10-23 Universal Preservation Technologies, Inc. Industrial scale barrier technology for preservation of sensitive biological materials at ambient temperatures
CN100425692C (zh) 1998-06-02 2008-10-15 株式会社富吉摩托普拉泽兹 含有高质量生理活性的家兔发痘组织的制造方法
CN1055249C (zh) * 1998-07-15 2000-08-09 沈继平 一种镇痛药和其制造方法
JP2000336034A (ja) 1999-03-19 2000-12-05 Nippon Zoki Pharmaceut Co Ltd ケモカイン産生促進剤
EP1046397A3 (en) 1999-04-15 2003-04-23 Nippon Zoki Pharmaceutical Co. Ltd. Novel bioactivating substance
US6726932B2 (en) 2000-02-18 2004-04-27 Nippon Zoki Pharmaceutical Co., Ltd. Fatty acid-containing composition
JP2004083487A (ja) * 2002-08-27 2004-03-18 Morinaga Milk Ind Co Ltd 抗ウイルス組成物及びウイルス感染症予防・治療用組成物
CA2503810C (en) 2002-10-31 2012-03-13 Kusuki Nishioka Therapeutic agent for fibromyalgia
CN1207005C (zh) 2002-10-31 2005-06-22 威世药业(如皋)有限公司 含生物活性物质的兔皮和其用途
JP2004300146A (ja) 2003-03-17 2004-10-28 Nippon Zoki Pharmaceut Co Ltd 感染防御剤
US7060308B2 (en) 2003-06-04 2006-06-13 Ramaswamy Rajendran Caralluma extract products and processes for making the same
JP3818657B2 (ja) 2004-12-01 2006-09-06 日本臓器製薬株式会社 乾燥物及びその製造方法
KR101307999B1 (ko) 2004-12-01 2013-09-12 니폰 조키 세야쿠 가부시키가이샤 건조물 및 그 제조방법
CN1613305B (zh) 2004-12-06 2011-01-12 威世药业(如皋)有限公司 一种从含新型活性物质的兔皮中提取的活性制剂
US20060134646A1 (en) 2004-12-17 2006-06-22 Ansari Aftab A Method for treatment of HIV infection
CN100542543C (zh) 2005-06-17 2009-09-23 日本脏器制药株式会社 干燥物及其制造法
TWI406664B (zh) 2006-03-30 2013-09-01 Univ Kyoto 硫氧還蛋白(thioredoxin)產生促進劑
EP2075341A4 (en) 2006-09-06 2010-09-08 Nippon Zoki Pharmaceutical Co METHOD FOR THE INVESTIGATION, DETERMINATION OR EVALUATION BY MEANS OF GENE EXPRESSION ANALYSIS
CN101790377A (zh) 2007-08-31 2010-07-28 国立大学法人九州大学 抗癌剂导致的末梢神经障碍的预防或减轻剂
TWI483729B (zh) 2010-03-11 2015-05-11 Nippon Zoki Pharmaceutical Co 慢性前列腺炎、間質性膀胱炎及/或排尿障礙之改善或治療劑
JP4899224B2 (ja) * 2010-05-11 2012-03-21 春三 小林 動脈硬化改善剤
WO2011162317A1 (ja) 2010-06-25 2011-12-29 日本臓器製薬株式会社 被検物質の判定又は評価方法
CA2808927C (en) 2010-10-14 2018-10-30 Nippon Zoki Pharmaceutical Co., Ltd. A method for promoting the synthesis of collagen and proteoglycan in chondrocytes
CN103357006B (zh) 2012-10-10 2014-10-15 日本脏器制药株式会社 含有提取物的制剂的检查方法
WO2014178394A1 (ja) * 2013-04-30 2014-11-06 日本臓器製薬株式会社 抽出物及び該抽出物を含有する製剤
US9764032B2 (en) 2015-02-11 2017-09-19 Rozita Moshtagh Multi-vitamin kids gummies having baobab and method of making thereof

Similar Documents

Publication Publication Date Title
JP2019073535A5 (https=)
Piran et al. The experience of embodiment scale: Development and psychometric evaluation
JP2019508789A5 (https=)
NZ619857A (en) A fast dissolving pharmaceutical composition
HRP20230253T1 (hr) Stabilna farmaceutska kompozicija za oralnu administraciju
Vasanthakumar et al. Plaque pH and dental retention after consumption of different types of chocolates
EP4575496A3 (en) Method of assessing growth hormone deficiency in humans by a macimorelin containing composition
CN104970771A (zh) 一种高精度的人体痛觉压力检测装置
Tabbakhian et al. Formulation and evaluation of orally disintegrating tablet of Rizatriptan using natural superdisintegrant
Dijkstra et al. Physical Threat and Self-Evaluative Emotions in Smoking Cessation.
Samnieng Prevalence of dental fear and its relationship with oral health in children
AR097591A1 (es) Métodos para determinar la respuesta a la terapia
CN103743831A (zh) 食品防腐剂山梨酸的检测方法
Guillot et al. Smoking history questionnaire
EP2763066A3 (en) Glucose meter
Ferenczi et al. Uses of Facebook Scale
Yongping et al. Research on stress wave tomography of spruce logs with artificial defects under different number sensors
JP1819611S (ja) 呼気成分検出・計測装置
Baudiß et al. Ceramide-1-phosphate attenuates cigarette smoke induce lung inflammation
RU2019121453A (ru) Способ диагностики заболеваний и состояний человеческого организма путём квазипостоянного измерения веса в динамике с учётом индивидуальных особенностей и изменений окружающей среды
JP2013242298A5 (https=)
Hara et al. A41 HERE THERE AND EVERYWHERE: ILD OBSERVATIONAL STUDIES: Clinical Importance Of Measuring Prostaglandin E-Major Urinary Metabolite (pge-Mum) In Fibrotic Lung Diseases (flds)
Davey et al. Subjective Smoking Norms Measure
Yinghong et al. Lessons from Transient “Triumphalism” in China's Neighboring Diplomacy
Olotu et al. A51 NEW INSIGHTS INTO PATHOGENS AND HOST DEFENSE: Phosphorylation Plays A Role In Streptococcus Pneumonia-Induced Inhibition Of Purinergic Signalling Cascade In Alveolar Epithelial Cells